{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:20:52Z","timestamp":1786112452786,"version":"build-2736575974"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1038\/s41380-026-03559-7","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T17:28:19Z","timestamp":1776274099000},"page":"4861-4873","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ethanolamine as a potential biomarker and therapeutic target for depressive disorder"],"prefix":"10.1038","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9568-8981","authenticated-orcid":false,"given":"Shintaro","family":"Ogawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4411-2317","authenticated-orcid":false,"given":"Kotaro","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsuke","family":"Hidese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3450-7283","authenticated-orcid":false,"given":"Daimei","family":"Sasayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8873-0822","authenticated-orcid":false,"given":"Miho","family":"Ota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Miyakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megumi","family":"Tatsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Matsumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumiko","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takamasa","family":"Noda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Takebayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2453-6080","authenticated-orcid":false,"given":"Wataru","family":"Omori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Itagaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7245-9206","authenticated-orcid":false,"given":"Naoto","family":"Kajitani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9541-1635","authenticated-orcid":false,"given":"Mami","family":"Okada-Tsuchioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9405-8235","authenticated-orcid":false,"given":"Akitoyo","family":"Hishimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuken","family":"Boku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadasu","family":"Horai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Monji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshito","family":"Mizoguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Tateishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Murakawa-Hirachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7637-5576","authenticated-orcid":false,"given":"Reiji","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryohei","family":"Igata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiharu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4548-7110","authenticated-orcid":false,"given":"Hiroaki","family":"Hori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7209-3790","authenticated-orcid":false,"given":"Hiroshi","family":"Kunugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"key":"3559_CR1","doi-asserted-by":"publisher","first-page":"e1001547","DOI":"10.1371\/journal.pmed.1001547","volume":"10","author":"AJ Ferrari","year":"2013","unstructured":"Ferrari AJ, Charlson FJ, Norman RE, Patten SB, Freedman G, Murray CJ, et al. Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010. PLoS Med. 2013;10:e1001547.","journal-title":"PLoS Med"},{"key":"3559_CR2","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1111\/pcn.12299","volume":"69","author":"H Kunugi","year":"2015","unstructured":"Kunugi H, Hori H, Ogawa S. Biochemical markers subtyping major depressive disorder. Psychiatry Clin Neurosci. 2015;69:597\u2013608.","journal-title":"Psychiatry Clin Neurosci"},{"key":"3559_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.acc.2022.09.001","volume":"112","author":"S Suseelan","year":"2023","unstructured":"Suseelan S, Pinna G. Heterogeneity in major depressive disorder: The need for biomarker-based personalized treatments. Adv Clin Chem. 2023;112:1\u201367.","journal-title":"Adv Clin Chem"},{"key":"3559_CR4","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1093\/psyrad\/kkac005","volume":"2","author":"X Chen","year":"2022","unstructured":"Chen X, Lu B, Li HX, Li XY, Wang YW, Castellanos FX, et al. The DIRECT consortium and the REST-meta-MDD project: towards neuroimaging biomarkers of major depressive disorder. Psychoradiology. 2022;2:32\u201342.","journal-title":"Psychoradiology"},{"key":"3559_CR5","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1038\/s41380-023-02193-x","volume":"28","author":"YT Hu","year":"2023","unstructured":"Hu YT, Tan ZL, Hirjak D, Northoff G. Brain-wide changes in excitation-inhibition balance of major depressive disorder: a systematic review of topographic patterns of GABA- and glutamatergic alterations. Mol Psychiatry. 2023;28:3257\u201366.","journal-title":"Mol Psychiatry"},{"key":"3559_CR6","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1176\/appi.ajp.2010.09091379","volume":"167","author":"T Insel","year":"2010","unstructured":"Insel T, Cuthbert B, Garvey M, Heinssen R, Pine DS, Quinn K, et al. Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. Am J Psychiatry. 2010;167:748\u201351.","journal-title":"Am J Psychiatry"},{"key":"3559_CR7","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ynstr.2017.03.003","volume":"7","author":"E Anderzhanova","year":"2017","unstructured":"Anderzhanova E, Kirmeier T, Wotjak CT. Animal models in psychiatric research: The RDoC system as a new framework for endophenotype-oriented translational neuroscience. Neurobiol Stress. 2017;7:47\u201356.","journal-title":"Neurobiol Stress"},{"key":"3559_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/srep07796","volume":"5","author":"S Ogawa","year":"2015","unstructured":"Ogawa S, Hattori K, Sasayama D, Yokota Y, Matsumura R, Matsuo J, et al. Reduced cerebrospinal fluid ethanolamine concentration in major depressive disorder. Sci Rep. 2015;5:7796.","journal-title":"Sci Rep"},{"key":"3559_CR9","doi-asserted-by":"publisher","first-page":"D521","DOI":"10.1093\/nar\/gkl923","volume":"35","author":"DS Wishart","year":"2007","unstructured":"Wishart DS, Tzur D, Knox C, Eisner R, Guo AC, Young N, et al. HMDB: the human metabolome database. Nucleic Acids Res. 2007;35:D521\u2013526.","journal-title":"Nucleic Acids Res"},{"key":"3559_CR10","doi-asserted-by":"publisher","first-page":"D1102","DOI":"10.1093\/nar\/gky1033","volume":"47","author":"S Kim","year":"2019","unstructured":"Kim S, Chen J, Cheng T, Gindulyte A, He J, He S, et al. PubChem 2019 update: improved access to chemical data. Nucleic Acids Res. 2019;47:D1102\u2013d1109.","journal-title":"Nucleic Acids Res"},{"key":"3559_CR11","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.bbalip.2014.11.005","volume":"1851","author":"F Dorninger","year":"2015","unstructured":"Dorninger F, Brodde A, Braverman NE, Moser AB, Just WW, Forss-Petter S, et al. Homeostasis of phospholipids - The level of phosphatidylethanolamine tightly adapts to changes in ethanolamine plasmalogens. Biochim Biophys Acta. 2015;1851:117\u201328.","journal-title":"Biochim Biophys Acta"},{"key":"3559_CR12","doi-asserted-by":"publisher","first-page":"760","DOI":"10.2174\/1570159X13666150612225212","volume":"13","author":"S Ogawa","year":"2015","unstructured":"Ogawa S, Kunugi H. Inhibitors of fatty acid amide hydrolase and monoacylglycerol lipase: new targets for future antidepressants. Curr Neuropharmacol. 2015;13:760\u201375.","journal-title":"Curr Neuropharmacol"},{"key":"3559_CR13","doi-asserted-by":"publisher","first-page":"4829180","DOI":"10.1155\/2017\/4829180","volume":"2017","author":"D Patel","year":"2017","unstructured":"Patel D, Witt SN. Ethanolamine and phosphatidylethanolamine: partners in health and disease. Oxid Med Cell Longev. 2017;2017:4829180.","journal-title":"Oxid Med Cell Longev"},{"key":"3559_CR14","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","volume":"23","author":"M Hamilton","year":"1960","unstructured":"Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56\u201362.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3559_CR15","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.psychres.2006.07.004","volume":"153","author":"H Tabuse","year":"2007","unstructured":"Tabuse H, Kalali A, Azuma H, Ozaki N, Iwata N, Naitoh H, et al. The new GRID hamilton rating scale for depression demonstrates excellent inter-rater reliability for inexperienced and experienced raters before and after training. Psychiatry Res. 2007;153:61\u201367.","journal-title":"Psychiatry Res"},{"key":"3559_CR16","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/sj.mp.4000485","volume":"4","author":"A Seretti","year":"1999","unstructured":"Seretti A, Cusin C, Lattuada E, Di Bella D, Catalano M, Smeraldi E. Serotonin transporter gene (5-HTTLPR) is not associated with depressive symptomatology in mood disorders. Mol Psychiatry. 1999;4:280\u20133.","journal-title":"Mol Psychiatry"},{"key":"3559_CR17","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1192\/bjp.133.5.429","volume":"133","author":"RC Young","year":"1978","unstructured":"Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. 1978;133:429\u201335.","journal-title":"Br J Psychiatry"},{"key":"3559_CR18","unstructured":"Naganuma H. Manic episode. Jpn J Clin Psychiatry. 1999;Suppl.:128\u201334."},{"key":"3559_CR19","doi-asserted-by":"publisher","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","volume":"10","author":"JE Overall","year":"1962","unstructured":"Overall JE, Gorham DR. The brief psychiatric rating scale. Psychol Rep. 1962;10:799\u2013812.","journal-title":"Psychol Rep"},{"key":"3559_CR20","first-page":"357","volume":"23","author":"R Miyata","year":"1995","unstructured":"Miyata R. Reliability of the japanese version of brief psychiatric rating scales (BPRS). Rinsho Hyoka. 1995;23:357.","journal-title":"Rinsho Hyoka"},{"key":"3559_CR21","unstructured":"Equivalent Doses of Psychotropic Medications. http:\/\/jsprs.org\/toukakansan\/index.html, 2020."},{"key":"3559_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/srep11412","volume":"5","author":"K Hattori","year":"2015","unstructured":"Hattori K, Ota M, Sasayama D, Yoshida S, Matsumura R, Miyakawa T, et al. Increased cerebrospinal fluid fibrinogen in major depressive disorder. Sci Rep. 2015;5:11412.","journal-title":"Sci Rep"},{"key":"3559_CR23","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.jpsychires.2010.03.006","volume":"44","author":"M Riedel","year":"2010","unstructured":"Riedel M, Moller HJ, Obermeier M, Schennach-Wolff R, Bauer M, Adli M, et al. Response and remission criteria in major depression-a validation of current practice. J Psychiatr Res. 2010;44:1063\u20138.","journal-title":"J Psychiatr Res"},{"key":"3559_CR24","doi-asserted-by":"publisher","first-page":"e947","DOI":"10.4088\/JCP.16m11144","volume":"78","author":"HS Yoon","year":"2017","unstructured":"Yoon HS, Hattori K, Ogawa S, Sasayama D, Ota M, Teraishi T, et al. Relationships of cerebrospinal fluid monoamine metabolite levels with clinical variables in major depressive disorder. J Clin Psychiatry. 2017;78:e947\u2013e956.","journal-title":"J Clin Psychiatry"},{"key":"3559_CR25","doi-asserted-by":"publisher","first-page":"D480","DOI":"10.1093\/nar\/gkaa1100","volume":"49","author":"UniProt Consortium","year":"2021","unstructured":"UniProt Consortium. UniProt: the universal protein knowledgebase in 2021. Nucleic Acids Res. 2021;49:D480\u2013d489.","journal-title":"Nucleic Acids Res"},{"key":"3559_CR26","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1097\/00019052-200312002-00002","volume":"16","author":"A Nieoullon","year":"2003","unstructured":"Nieoullon A, Coquerel A. Dopamine: a key regulator to adapt action, emotion, motivation and cognition. Curr Opin Neurol. 2003;16:S3\u20139.","journal-title":"Curr Opin Neurol"},{"key":"3559_CR27","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1515\/revneuro-2012-0060","volume":"23","author":"A Meneses","year":"2012","unstructured":"Meneses A, Liy-Salmeron G. Serotonin and emotion, learning and memory. Rev Neurosci. 2012;23:543\u201353.","journal-title":"Rev Neurosci"},{"key":"3559_CR28","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41380-019-0406-4","volume":"25","author":"B Conio","year":"2020","unstructured":"Conio B, Martino M, Magioncalda P, Escelsior A, Inglese M, Amore M, et al. Opposite effects of dopamine and serotonin on resting-state networks: review and implications for psychiatric disorders. Mol Psychiatry. 2020;25:82\u201393.","journal-title":"Mol Psychiatry"},{"key":"3559_CR29","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jpsychires.2018.08.028","volume":"105","author":"S Ogawa","year":"2018","unstructured":"Ogawa S, Tsuchimine S, Kunugi H. Cerebrospinal fluid monoamine metabolite concentrations in depressive disorder: A meta-analysis of historic evidence. J Psychiatr Res. 2018;105:137\u201346.","journal-title":"J Psychiatr Res"},{"key":"3559_CR30","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.jad.2015.06.051","volume":"186","author":"M Ota","year":"2015","unstructured":"Ota M, Noda T, Sato N, Okazaki M, Ishikawa M, Hattori K, et al. Effect of electroconvulsive therapy on gray matter volume in major depressive disorder. J Affect Disord. 2015;186:186\u201391.","journal-title":"J Affect Disord"},{"key":"3559_CR31","doi-asserted-by":"publisher","first-page":"114947","DOI":"10.1016\/j.fct.2024.114947","volume":"192","author":"L Sampedro","year":"2024","unstructured":"Sampedro L, Casado A, Redruello B, Del Rio B, Alvarez MA. Do the biogenic amines ethylamine, ethanolamine and methylamine reach toxic concentrations in foods? Food Chem Toxicol. 2024;192:114947.","journal-title":"Food Chem Toxicol"},{"key":"3559_CR32","doi-asserted-by":"publisher","first-page":"171","DOI":"10.2217\/pgs.10.185","volume":"12","author":"A Morag","year":"2011","unstructured":"Morag A, Pasmanik-Chor M, Oron-Karni V, Rehavi M, Stingl JC, Gurwitz D. Genome-wide expression profiling of human lymphoblastoid cell lines identifies CHL1 as a putative SSRI antidepressant response biomarker. Pharmacogenomics. 2011;12:171\u201384.","journal-title":"Pharmacogenomics"},{"key":"3559_CR33","doi-asserted-by":"publisher","first-page":"689","DOI":"10.2217\/pgs.15.31","volume":"16","author":"K Probst-Schendzielorz","year":"2015","unstructured":"Probst-Schendzielorz K, Scholl C, Efimkina O, Ersfeld E, Viviani R, Serretti A, et al. CHL1, ITGB3 and SLC6A4 gene expression and antidepressant drug response: results from the Munich Antidepressant Response Signature (MARS) study. Pharmacogenomics. 2015;16:689\u2013701.","journal-title":"Pharmacogenomics"},{"key":"3559_CR34","doi-asserted-by":"publisher","first-page":"e10841","DOI":"10.7554\/eLife.10841","volume":"4","author":"S Poliak","year":"2015","unstructured":"Poliak S, Morales D, Croteau LP, Krawchuk D, Palmesino E, Morton S, et al. Synergistic integration of Netrin and ephrin axon guidance signals by spinal motor neurons. eLife. 2015;4:e10841.","journal-title":"eLife"},{"key":"3559_CR35","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1002\/dvdy.24609","volume":"247","author":"SA Russell","year":"2018","unstructured":"Russell SA, Bashaw GJ. Axon guidance pathways and the control of gene expression. Dev Dyn. 2018;247:571\u201380.","journal-title":"Dev Dyn"},{"key":"3559_CR36","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1080\/00031305.2018.1564697","volume":"73","author":"WM Goodman","year":"2019","unstructured":"Goodman WM, Spruill SE, Komaroff E. A proposed hybrid effect size plus p-value criterion: empirical evidence supporting its use. Am Stat. 2019;73:168\u201385.","journal-title":"Am Stat"},{"key":"3559_CR37","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1159\/000441457","volume":"85","author":"AF Carvalho","year":"2016","unstructured":"Carvalho AF, K\u00f6hler CA, Brunoni AR, Miskowiak KW, Herrmann N, Lanct\u00f4t KL, et al. Bias in Peripheral Depression Biomarkers. Psychother Psychosom. 2016;85:81\u201390.","journal-title":"Psychother Psychosom"},{"key":"3559_CR38","doi-asserted-by":"publisher","first-page":"e0141564","DOI":"10.1371\/journal.pone.0141564","volume":"10","author":"M Polyakova","year":"2015","unstructured":"Polyakova M, Schroeter ML, Elzinga BM, Holiga S, Schoenknecht P, de Kloet ER, et al. Brain-derived neurotrophic factor and antidepressive effect of electroconvulsive therapy: systematic review and meta-analyses of the preclinical and clinical literature. PLoS ONE. 2015;10:e0141564.","journal-title":"PLoS ONE"},{"key":"3559_CR39","doi-asserted-by":"publisher","first-page":"1181973","DOI":"10.3389\/fimmu.2023.1181973","volume":"14","author":"R Yin","year":"2023","unstructured":"Yin R, Zhang K, Li Y, Tang Z, Zheng R, Ma Y, et al. Lipopolysaccharide-induced depression-like model in mice: meta-analysis and systematic evaluation. Front Immunol. 2023;14:1181973.","journal-title":"Front Immunol"},{"key":"3559_CR40","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1007\/s43440-022-00420-w","volume":"74","author":"J Kryst","year":"2022","unstructured":"Kryst J, Majcher-Ma\u015blanka I, Chocyk A. Effects of chronic fluoxetine treatment on anxiety- and depressive-like behaviors in adolescent rodents - systematic review and meta-analysis. Pharmacol Rep. 2022;74:920\u201346.","journal-title":"Pharmacol Rep"},{"key":"3559_CR41","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s11154-021-09688-4","volume":"23","author":"W Ratajczak","year":"2022","unstructured":"Ratajczak W, Atkinson SD, Kelly C. The TWEAK\/Fn14\/CD163 axis-implications for metabolic disease. Rev Endocr Metab Disord. 2022;23:449\u201362.","journal-title":"Rev Endocr Metab Disord"},{"key":"3559_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06639-0","volume":"15","author":"X Huang","year":"2024","unstructured":"Huang X, Qi J, Su Y, Zhou Y, Wang Q, Huang T, et al. Endothelial DR6 in blood-brain barrier malfunction in Alzheimer\u2019s disease. Cell Death Dis. 2024;15:258.","journal-title":"Cell Death Dis"},{"key":"3559_CR43","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.cell.2016.10.025","volume":"167","author":"P Li","year":"2016","unstructured":"Li P, Liu S, Lu M, Bandyopadhyay G, Oh D, Imamura T, et al. Hematopoietic-derived galectin-3 causes cellular and systemic insulin resistance. Cell. 2016;167:973\u2013.84e912.","journal-title":"Cell"},{"key":"3559_CR44","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1038\/ng0904-934","volume":"36","author":"RA Black","year":"2004","unstructured":"Black RA. TIMP3 checks inflammation. Nat Genet. 2004;36:934\u20135.","journal-title":"Nat Genet"},{"key":"3559_CR45","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.devcel.2011.11.018","volume":"22","author":"SJ Tam","year":"2012","unstructured":"Tam SJ, Richmond DL, Kaminker JS, Modrusan Z, Martin-McNulty B, Cao TC, et al. Death receptors DR6 and TROY regulate brain vascular development. Dev Cell. 2012;22:403\u201317.","journal-title":"Dev Cell"},{"key":"3559_CR46","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1093\/brain\/awz376","volume":"143","author":"CR Fagerberg","year":"2020","unstructured":"Fagerberg CR, Taylor A, Distelmaier F, Schr\u00f8der HD, Kib\u00e6k M, Wieczorek D, et al. Choline transporter-like 1 deficiency causes a new type of childhood-onset neurodegeneration. Brain. 2020;143:94\u2013111.","journal-title":"Brain"},{"key":"3559_CR47","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.3390\/nu11102265","volume":"11","author":"M Inazu","year":"2019","unstructured":"Inazu M. Functional expression of choline transporters in the blood-brain barrier. Nutrients. 2019;11:2265.","journal-title":"Nutrients"},{"key":"3559_CR48","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.bbamem.2016.09.023","volume":"1859","author":"J Neumann","year":"2017","unstructured":"Neumann J, Rose-Sperling D, Hellmich UA. Diverse relations between ABC transporters and lipids: An overview. Biochim Biophys Acta Biomembr. 2017;1859:605\u201318.","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"3559_CR49","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/(SICI)1520-6769(199603)18:2<87::AID-NRC144>3.0.CO;2-C","volume":"18","author":"DL Marshall","year":"1996","unstructured":"Marshall DL, De Micheli E, Bogdanov MB, Wurtman RJ. Effects of ethanolamine (Etn) administration on Etn and choline (Ch) levels in plasma, brain extracellular fluid (ECF) and brain tissue, and on brain phospholipid levels in rats: an in vivo study. Neurosci Res Commun. 1996;18:87\u201396.","journal-title":"Neurosci Res Commun"},{"key":"3559_CR50","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.foodcont.2015.11.009","volume":"62","author":"AC Manetta","year":"2016","unstructured":"Manetta AC, Di Giuseppe L, Tofalo R, Martuscelli M, Schirone M, Giammarco M, et al. Evaluation of biogenic amines in wine: determination by an improved HPLC-PDA method. Food Control. 2016;62:351\u20136.","journal-title":"Food Control"},{"key":"3559_CR51","doi-asserted-by":"publisher","first-page":"3251","DOI":"10.1016\/j.chroma.2009.09.027","volume":"1217","author":"HK Mayer","year":"2010","unstructured":"Mayer HK, Fiechter G, Fischer E. A new ultra-pressure liquid chromatography method for the determination of biogenic amines in cheese. J Chromatogr A. 2010;1217:3251\u20137.","journal-title":"J Chromatogr A"},{"key":"3559_CR52","doi-asserted-by":"publisher","first-page":"3026","DOI":"10.1021\/jf204900v","volume":"60","author":"CM Mayr","year":"2012","unstructured":"Mayr CM, Schieberle P. Development of stable isotope dilution assays for the simultaneous quantitation of biogenic amines and polyamines in foods by LC-MS\/MS. J Agric Food Chem. 2012;60:3026\u201332.","journal-title":"J Agric Food Chem"},{"key":"3559_CR53","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.foodchem.2009.02.015","volume":"116","author":"B Ramos","year":"2009","unstructured":"Ramos B, Pinho O. Ferreira IMPLVO. Changes of yolk biogenic amine concentrations during storage of shell hen eggs. Food Chem. 2009;116:340\u20134.","journal-title":"Food Chem"},{"issue":"9","key":"3559_CR54","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1016\/j.bbadis.2012.05.008","volume":"1822","author":"NE Braverman","year":"2012","unstructured":"Braverman NE, Moser AB. Functions of plasmalogen lipids in health and disease. Biochim Biophys Acta. 2012;1822:1442\u201352.","journal-title":"Biochim Biophys Acta"},{"key":"3559_CR55","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.plipres.2010.02.003","volume":"49","author":"N Ueda","year":"2010","unstructured":"Ueda N, Tsuboi K, Uyama T. N-acylethanolamine metabolism with special reference to N-acylethanolamine-hydrolyzing acid amidase (NAAA). Prog Lipid Res. 2010;49:299\u2013315.","journal-title":"Prog Lipid Res"},{"key":"3559_CR56","unstructured":"Morell P, Quarles RH Characteristic composition of myelin. In: Siegel GJ, Agranoff BW, Albers RW, et al. (eds). Basic Neurochemistry: Molecular, Cellular and Medical Aspects, 6th edn. Lippincott-Raven: Philadelphia, 1999."},{"key":"3559_CR57","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/pcn.12967","volume":"74","author":"S Ogawa","year":"2020","unstructured":"Ogawa S, Hattori K, Ota M, Hidese S, Miyakawa T, Matsumura R, et al. Altered ethanolamine plasmalogen and phosphatidylethanolamine levels in blood plasma of patients with bipolar disorder. Psychiatry Clin Neurosci. 2020;74:204\u201310.","journal-title":"Psychiatry Clin Neurosci"},{"key":"3559_CR58","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/ijnp\/pyz005","volume":"22","author":"K Itagaki","year":"2019","unstructured":"Itagaki K, Takebayashi M, Abe H, Shibasaki C, Kajitani N, Okada-Tsuchioka M, et al. Reduced serum and cerebrospinal fluid levels of autotaxin in major depressive disorder. Int J Neuropsychopharmacol. 2019;22:261\u20139.","journal-title":"Int J Neuropsychopharmacol"},{"key":"3559_CR59","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1093\/ijnp\/pyab044","volume":"24","author":"W Omori","year":"2021","unstructured":"Omori W, Kano K, Hattori K, Kajitani N, Okada-Tsuchioka M, Boku S, et al. Reduced cerebrospinal fluid levels of lysophosphatidic acid docosahexaenoic acid in patients with major depressive disorder and schizophrenia. Int J Neuropsychopharmacol. 2021;24:948\u201355.","journal-title":"Int J Neuropsychopharmacol"},{"key":"3559_CR60","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41586-024-07444-7","volume":"630","author":"K Ri","year":"2024","unstructured":"Ri K, Weng TH, Claveras Cabezudo A, J\u00f6sting W, Zhang Y, Bazzone A, et al. Molecular mechanism of choline and ethanolamine transport in humans. Nature. 2024;630:501\u20138.","journal-title":"Nature"},{"key":"3559_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2024.105789","volume":"164","author":"JE Pestana","year":"2024","unstructured":"Pestana JE, Graham BM. The impact of estrous cycle on anxiety-like behaviour during unlearned fear tests in female rats and mice: A systematic review and meta-analysis. Neurosci Biobehav Rev. 2024;164:105789.","journal-title":"Neurosci Biobehav Rev"},{"key":"3559_CR62","doi-asserted-by":"publisher","first-page":"104962","DOI":"10.1016\/j.neubiorev.2022.104962","volume":"143","author":"AM Kaluve","year":"2022","unstructured":"Kaluve AM, Le JT, Graham BM. Female rodents are not more variable than male rodents: A meta-analysis of preclinical studies of fear and anxiety. Neurosci Biobehav Rev. 2022;143:104962.","journal-title":"Neurosci Biobehav Rev"},{"key":"3559_CR63","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.neuropharm.2015.03.016","volume":"99","author":"N Kokras","year":"2015","unstructured":"Kokras N, Antoniou K, Mikail HG, Kafetzopoulos V, Papadopoulou-Daifoti Z, Dalla C. Forced swim test: What about females? Neuropharmacology. 2015;99:408\u201321.","journal-title":"Neuropharmacology"},{"key":"3559_CR64","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/266730a0","volume":"266","author":"RD Porsolt","year":"1977","unstructured":"Porsolt RD, Le Pichon M, Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature. 1977;266:730\u20132.","journal-title":"Nature"},{"key":"3559_CR65","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/0014-2999(78)90118-8","volume":"47","author":"RD Porsolt","year":"1978","unstructured":"Porsolt RD, Anton G, Blavet N, Jalfre M. Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol. 1978;47:379\u201391.","journal-title":"Eur J Pharmacol"},{"key":"3559_CR66","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41380-022-01762-w","volume":"28","author":"IA von M\u00fccke-Heim","year":"2023","unstructured":"von M\u00fccke-Heim IA, Urbina-Trevi\u00f1o L, Bordes J, Ries C, Schmidt MV, Deussing JM. Introducing a depression-like syndrome for translational neuropsychiatry: a plea for taxonomical validity and improved comparability between humans and mice. Mol Psychiatry. 2023;28:329\u201340.","journal-title":"Mol Psychiatry"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03559-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03559-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03559-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T15:03:18Z","timestamp":1785942198000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03559-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":66,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["3559"],"URL":"https:\/\/doi.org\/10.1038\/s41380-026-03559-7","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]},"assertion":[{"value":"2 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}